Literature DB >> 18072176

Case files of the Drexel University Medical Toxicology Fellowship: methadone-induced QTc prolongation.

Stella C Wong1, James R Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18072176      PMCID： PMC3550015          DOI： 10.1007/bf03160939

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  22 in total

1.  Can methadone prolong the QT interval?

Authors:  J A Decerf; B Gressens; C Brohet; A Liolios; P Hantson
Journal:  Intensive Care Med       Date:  2004-06-08       Impact factor: 17.440

Review 2.  QT interval prolongation in patients on methadone with concomitant drugs.

Authors:  Valerie Piguet; Jules Desmeules; Georg Ehret; Rudolf Stoller; Pierre Dayer
Journal:  J Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.153

3.  Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes.

Authors:  Suresh Reddy; Michael Fisch; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2004-10       Impact factor: 3.612

4.  Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.

Authors:  Alexander N Katchman; Kelly A McGroary; Michael J Kilborn; Craig A Kornick; Paolo L Manfredi; Raymond L Woosley; Steven N Ebert
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

Review 5.  What clinicians should know about the QT interval.

Authors:  Sana M Al-Khatib; Nancy M Allen LaPointe; Judith M Kramer; Robert M Califf
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

6.  Cocaine abuse: repolarization abnormalities and ventricular arrhythmias.

Authors:  G A Gamouras; G Monir; K Plunkitt; S Gursoy; L S Dreifus
Journal:  Am J Med Sci       Date:  2000-07       Impact factor: 2.378

7.  A twist on torsade: a prolonged QT interval on methadone.

Authors:  Patricia Lamont; Susan C Hunt
Journal:  J Gen Intern Med       Date:  2006-11       Impact factor: 5.128

8.  Torsade de pointes associated with very-high-dose methadone.

Authors:  Mori J Krantz; Laurent Lewkowiez; Helen Hays; Mary Ann Woodroffe; Alastair D Robertson; Philip S Mehler
Journal:  Ann Intern Med       Date:  2002-09-17       Impact factor: 25.391

Review 9.  Toxicologic myocardial sensitization.

Authors:  Lewis S Nelson
Journal:  J Toxicol Clin Toxicol       Date:  2002

10.  QTc interval prolongation associated with intravenous methadone.

Authors:  Craig A Kornick; Michael J Kilborn; Juan Santiago-Palma; Glenn Schulman; Howard T Thaler; Deborah L Keefe; Alexander N Katchman; John C Pezzullo; Steven N Ebert; Raymond L Woosley; Richard Payne; Paolo L Manfredi
Journal:  Pain       Date:  2003-10       Impact factor: 6.961
View more
  4 in total

1.  Drug-specific risk of severe QT prolongation following acute drug overdose.

Authors:  Sharan L Campleman; Jeffery Brent; Anthony F Pizon; Joshua Shulman; Paul Wax; Alex F Manini
Journal:  Clin Toxicol (Phila)       Date:  2020-04-07       Impact factor: 4.467

2.  QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel.

Authors:  Judith A Martin; Anthony Campbell; Thomas Killip; Margaret Kotz; Mori J Krantz; Mary Jeanne Kreek; Brian A McCarroll; Davendra Mehta; J Thomas Payte; Barry Stimmel; Trusandra Taylor; Mark C P Haigney; Bonnie B Wilford
Journal:  J Addict Dis       Date:  2011-10

3.  Opioid and other substance misuse, overdose risk, and the potential for prevention among a sample of OEF/OIF veterans in New York City.

Authors:  Alex S Bennett; Luther Elliott; Andrew Golub
Journal:  Subst Use Misuse       Date:  2013-07       Impact factor: 2.164

4.  Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem.

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; Thomas Clausen; Jayanthi N Koneru; Christopher Kogut; Ericka L Breden Crouse; Jules C Hancox; Antony Fernandez; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2013-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.